tetrachloroisophthalonitrile has been researched along with insulin glargine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsaleh, AJO; Fonseca, V; Gill, J; Nicholls, C; Shao, H; Shi, L | 1 |
1 trial(s) available for tetrachloroisophthalonitrile and insulin glargine
| Article | Year |
|---|---|
Cost-effectiveness analysis of once-daily insulin glargine 300 U/mL versus insulin degludec 100 U/mL using the BRAVO diabetes model.
Topics: Adult; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine | 2023 |